Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Politics & Policy
February 08, 2022 04:26 PM

Report: Opioid fight needs new strategy, Cabinet leadership

Associated Press
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Getty Images/iStockphoto
    A large group of prescription medication bottles sit on a table in front of a distraught man who is leaning on his hand as he sits at his dining room table. The image is photographed with a very shallow depth of field with the focus being on the pill bottles in the foreground.

    The U.S. needs a nimble, multipronged strategy and Cabinet-level leadership to counter its festering overdose epidemic, a bipartisan congressional commission advises.

    With vastly powerful synthetic drugs like fentanyl driving record overdose deaths, the scourge of opioids awaits after the COVID-19 pandemic finally recedes, a shift that public health experts expect in the months ahead.

    "This is one of our most pressing national security, law enforcement and public health challenges, and we must do more as a nation and a government to protect our most precious resource — American lives," the Commission on Combating Synthetic Opioid Trafficking said in a 70-page report released Tuesday.

    The report envisions a dynamic strategy. It would rely on law enforcement and diplomacy to shut down sources of chemicals used to make synthetic opioids. It would offer treatment and support for people who become addicted, creating pathways that can lead back to productive lives. And it would invest in research to better understand addiction's grip on the human brain and to develop treatments for opioid use disorder.

    The global coronavirus pandemic has overshadowed the American opioid epidemic for the last two years, but recent news that overdose deaths surpassed 100,000 in one year caught the public's attention. Politically, federal legislation to address the opioid crisis won support across the partisan divide during both the Obama and Trump administrations.

    Read more: 
    U.S. overdose deaths topped 100,000 in one year, officials say
    Two powerful drugs now adding to U.S. overdose crisis
    U.S. sets new record for drug overdose deaths at 95,000
    U.S. overdose deaths hit record 93,000 in pandemic last year

    Rep. David Trone, D-Md., a co-chair of the panel that produced the report, said he believes that support is still there, and that the issue appeals to Biden's pragmatic side. "The president has been crystal clear," Trone said. "These are two major issues in America: addiction and mental health." Trone's counterpart was Sen. Tom Cotton, R-Ark.

    The U.S. government has been waging a losing "war on drugs" for decades.

    Not a Modern Healthcare subscriber? Sign up today.

    Related Articles
    Native American tribes reach $590 million opioid settlement
    As COVID fueled the drug crisis, Native Americans hit worst
    Cities wracked by opioids close to getting $26B settlement
    Jury holds CVS, Walgreens and Walmart pharmacies responsible for role in opioid crisis
    Washington seeks over $38 billion from opioid distributors

    The stakes are much higher now with the widespread availability of fentanyl, a synthetic painkiller 80 to 100 times more powerful than morphine. It can be baked into illicit pills made to look like prescription painkillers or anti-anxiety medicines. The chemical raw materials are produced mainly in China. Criminal networks in Mexico control the production and shipment to the U.S.

    Federal anti-drug strategy traditionally emphasized law enforcement and long prison sentences. But that came to be seen as tainted by racial bias and counter-productive because drug use is treatable. The value of treatment has recently has gained recognition with anti-addiction medicines in wide use alongside older strategies like support groups. 

    The report endorsed both law enforcement and treatment, working in sync with one another.

    "Through its work, the commission came to recognize the impossibility of reducing the availability of illegal synthetic opioids through efforts focused on supply alone," the report said.

    "Real progress can come only by pairing illicit synthetic opioid supply disruption with decreasing the domestic U.S. demand for these drugs," it added.

    Five "pillars" for government action:

    — Elevating the White House Office of National Drug Control Policy to act as the nerve center for far-flung federal efforts, and restoring Cabinet rank to its director.

    — Disrupting the supply of drugs through better coordinated law enforcement actions.

    — Reducing the demand for illicit drugs through treatment and by efforts to mitigate the harm to people addicted. Treatment programs should follow science-based "best practices."

    — Using diplomacy to enlist help from other governments in cutting off the supply of chemicals that criminal networks use to manufacture fentanyl.

    — Developing surveillance and data analysis tools to spot new trends in illicit drug use before they morph into major problems for society.

    The report recommends what it calls five "pillars" for government action:

    — Elevating the White House Office of National Drug Control Policy to act as the nerve center for far-flung federal efforts, and restoring Cabinet rank to its director.

    — Disrupting the supply of drugs through better coordinated law enforcement actions.

    — Reducing the demand for illicit drugs through treatment and by efforts to mitigate the harm to people addicted. Treatment programs should follow science-based "best practices."

    — Using diplomacy to enlist help from other governments in cutting off the supply of chemicals that criminal networks use to manufacture fentanyl.

    — Developing surveillance and data analysis tools to spot new trends in illicit drug use before they morph into major problems for society.

    Participating as non-voting members in the commission's work were high-level executive branch officials, including representatives from law enforcement, the departments of State, Treasury and Homeland Security, the intelligence community, and the White House. Administration officials said Biden has already issued two executive orders to counter fentanyl trafficking and called on Congress to pass his $41 billion request to address the overdose epidemic.

    In prepared statements, Republican commission members stressed the law enforcement response. "We must redouble our efforts to secure the border against illegal trafficking by targeting Mexican cartels flooding our streets with illicit opioids and force China's hand to crackdown on their pharmaceutical industry supplying cartels with the base compounds used to manufacture synthetic opioids," said Rep. Fred Upton, R-Mich.

    Trone said it's going to take cooperation from both political parties. "We have to take this toxic atmosphere in Washington and move past it," he said. "Because 100,000 people, that's husbands, sisters, mothers, fathers. As a country, we are better than that."

    Related Articles
    The powerful pairing of telemedicine and opioid addiction treatment
    In pandemic, drug overdose deaths soar among Black Americans
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    capitol hill
    Debt ceiling agreement impacts health programs, but it could've been worse
    Copy of 110220-regionals2-medicaid_WEB_i.jpg
    CMS urges states to stem Medicaid losses during redeterminations
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing